ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones

Thanks to its partners in research, medicine, its bioproduct suppliers and its shareholders, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.

ABIONYX Pharma is scaling up its operations after securing the resources needed to achieve its goals and is embarking on a new cycle of value creation in the treatment of severe inflammation and sepsis  - PDF